WallStreetZenWallStreetZen

NASDAQ: AQST
Aquestive Therapeutics Inc Stock Ownership - Who owns Aquestive Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Aquestive Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Alexander Mark SchobelChief InnovationTech Officer2024-03-1550,000$6.00
$300.00kSell
Stephen WargackiSVP Research Development2024-03-101,687$4.88
$8.23kSell
Cassie JungSVP Operations2024-03-101,132$4.88
$5.52kSell
Cassie JungSVP Operations2024-03-098,300$4.88
$40.50kSell
Alexander Mark SchobelChief InnovationTech Officer2024-03-095,895$4.88
$28.77kSell
A. Ernest Toth Jr.SVP Chief Financial Officer2024-03-0911,705$4.88
$57.12kSell
Stephen WargackiSVP Research Development2024-03-0911,269$4.88
$54.99kSell
Daniel BarberPresident and CEO2024-03-0937,938$4.88
$185.14kSell
Peter E. BoydSVP Information Technology Human Resources and Communications2024-03-098,370$4.88
$40.85kSell
Lori J. BraenderSVP General Counsel2024-03-0910,530$4.88
$51.39kSell

1 of 2

AQST insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AQST insiders and whales buy or sell their stock.

AQST Shareholders

What type of owners hold Aquestive Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Bratton Capital Management LP13.38%9,810,958$42.97MInstitution
Armistice Capital LLC5.35%3,924,000$17.19MInstitution
Douglas K. Bratton2.68%1,961,163$8.59MInsider
Vanguard Group Inc2.58%1,889,053$8.27MInstitution
Renaissance Technologies LLC1.73%1,271,500$5.57MInstitution
Alexander Mark Schobel1.34%984,476$4.31MInsider
Essex Investment Management Co LLC1.15%846,167$3.71MInstitution
Daniel Barber1.15%845,364$3.70MInsider
Keith J. Kendall0.87%639,149$2.80MInsider
Vahanian Associates Financial Planning Inc0.81%591,608$2.59MInstitution

1 of 3

AQST vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AQST32.45%9.23%Net SellingNet Selling
PROC0.22%76.27%
KMDA10.06%0.00%
ACB54.59%0.00%
HROW30.74%69.26%Net SellingNet Buying
View Top Pharmaceutical Stocks

Aquestive Therapeutics Stock Ownership FAQ

Who owns Aquestive Therapeutics?

Aquestive Therapeutics (NASDAQ: AQST) is owned by 32.45% institutional shareholders, 9.23% Aquestive Therapeutics insiders, and 58.32% retail investors. Douglas K. Bratton is the largest individual Aquestive Therapeutics shareholder, owning 1.96M shares representing 2.68% of the company. Douglas K. Bratton's Aquestive Therapeutics shares are currently valued at $8.39M.

If you're new to stock investing, here's how to buy Aquestive Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.